• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

华盛顿特区肝细胞癌发病率趋势:一项单机构队列研究(1959-2013 年)。

Trends in the Incidence of Hepatocellular Carcinoma in Washington DC: A Single Institutional Cohort Study (1959-2013).

机构信息

Department of Biochemistry & Molecular Biology, Howard University College of Medicine, Washington, DC, USA.

Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, USA.

出版信息

J Natl Med Assoc. 2021 Aug;113(4):396-404. doi: 10.1016/j.jnma.2021.02.001. Epub 2021 Feb 27.

DOI:10.1016/j.jnma.2021.02.001
PMID:33648723
Abstract

The African American (AA) community in Washington DC is at an elevated risk for hepatocellular carcinoma (HCC) that has a dismal prognosis. The recent rapid increase in the incidence and diagnosis of HCC and liver metastases (LM) in DC prompted us to evaluate the past six decades of this incidence and some of its underlying causes using a single institutional cohort in a hospital located in the center of the city. Electronic medical and pathology records of 454 liver cancer patients from 1959 to 2013 at Howard University Hospital (HUH) were reviewed. Demographic, clinical and pathology characteristics were examined, and statistical analysis was performed using Wilcoxon rank-sum test. Incidence of HCC rose substantially between 1959 and 2013, increasing eight-fold from 1.05 to 8.0 per 100,000 AAs. The rate of increase in the last decade was highest at 550%. Cases were disproportionately male (67.2%), and median age at diagnosis was 57 years. Towards the last decade, the most common etiology for HCC was nonalcoholic fatty liver disease (NAFLD) followed by NAFLD/HCV combination. Liver cancer was clustered in the eastern region of DC in wards 4, 5, 7, and 8. Cases of liver metastases clinically diagnosed and confirmed by biopsies increased 96.4% from 1959 to 1968 to 2009-2013. This study confirms that HCC incidence has been increasing (initially driven by HCV, and NAFLD in the latter decades) more rapidly in DC than previously believed, highlighting the impact of case definitions especially regarding NAFLD in the context of changing diagnostic approaches including the revised ICD10. The rising burden, disproportionate population distribution, and low survival rate among AAs emphasize the importance of prevention and early detection as a public health imperative.

摘要

华盛顿特区的非裔美国人(AA)群体患肝细胞癌(HCC)的风险较高,而 HCC 的预后较差。最近,DC 肝癌和肝转移(LM)的发病率和诊断率迅速上升,促使我们利用位于市中心医院的单一机构队列,评估过去六十年的 HCC 发病率和一些潜在病因。回顾了霍华德大学医院(HUH) 1959 年至 2013 年间 454 例肝癌患者的电子病历和病理记录。检查了人口统计学、临床和病理学特征,并使用 Wilcoxon 秩和检验进行了统计分析。1959 年至 2013 年间,HCC 的发病率大幅上升,从每 10 万 AA 中 1.05 例增加到 8.0 例,增加了 8 倍。过去十年的增长率最高,为 550%。病例中男性比例偏高(67.2%),诊断时的中位年龄为 57 岁。在过去十年中,HCC 的最常见病因是非酒精性脂肪性肝病(NAFLD),其次是 NAFLD/HCV 联合。肝癌集中在 DC 的东部地区,包括第 4、5、7 和 8 病房。临床诊断和活检证实的肝转移病例从 1959 年至 1968 年增加了 96.4%,达到 2009 年至 2013 年。这项研究证实,HCC 的发病率在 DC 比之前认为的增长更快(最初由 HCV 驱动,而在最近几十年则由 NAFLD 驱动),突出了病例定义的影响,尤其是在包括 ICD10 修订版在内的诊断方法改变的情况下。非裔美国人的负担不断增加、人口分布不均以及生存率低,强调了预防和早期检测作为公共卫生当务之急的重要性。

相似文献

1
Trends in the Incidence of Hepatocellular Carcinoma in Washington DC: A Single Institutional Cohort Study (1959-2013).华盛顿特区肝细胞癌发病率趋势:一项单机构队列研究(1959-2013 年)。
J Natl Med Assoc. 2021 Aug;113(4):396-404. doi: 10.1016/j.jnma.2021.02.001. Epub 2021 Feb 27.
2
Hepatocellular carcinoma over three decades in Victoria, Australia: epidemiology, diagnosis and trends, 1984-2013.澳大利亚维多利亚州三十年肝细胞癌研究:1984 - 2013年的流行病学、诊断及趋势
Intern Med J. 2018 Jul;48(7):835-844. doi: 10.1111/imj.13823.
3
Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population.退伍军人事务人群中与非酒精性脂肪性肝病相关的肝细胞癌的时间趋势。
Clin Gastroenterol Hepatol. 2015 Mar;13(3):594-601.e1. doi: 10.1016/j.cgh.2014.08.013. Epub 2014 Aug 19.
4
Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.非肝硬化非酒精性脂肪性肝病和代谢综合征背景下的肝细胞癌:美国的经验
Dig Dis Sci. 2015 Oct;60(10):3142-8. doi: 10.1007/s10620-015-3821-7. Epub 2015 Aug 7.
5
Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.伴有非酒精性脂肪性肝病/非酒精性脂肪性肝炎的丙型肝炎病毒相关肝硬化中的肝细胞癌的特殊组织学变异型:脂肪性肝炎相关肝细胞癌。
Am J Surg Pathol. 2010 Nov;34(11):1630-6. doi: 10.1097/PAS.0b013e3181f31caa.
6
Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.2001-2013 年美国退伍军人中潜在肝脏疾病导致的肝硬化和肝细胞癌负担趋势。
Gastroenterology. 2015 Nov;149(6):1471-1482.e5; quiz e17-8. doi: 10.1053/j.gastro.2015.07.056. Epub 2015 Aug 5.
7
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.AGA 临床实践更新:非酒精性脂肪性肝病患者肝细胞癌的筛查和监测:专家综述。
Gastroenterology. 2020 May;158(6):1822-1830. doi: 10.1053/j.gastro.2019.12.053. Epub 2020 Jan 30.
8
Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies.非酒精性脂肪性肝病相关肝细胞癌的临床特征:一项人体研究综述
Clin J Gastroenterol. 2015 Feb;8(1):1-9. doi: 10.1007/s12328-014-0548-5. Epub 2015 Jan 10.
9
The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease.不同临床非肝硬化非酒精性脂肪性肝病风险分层中肝细胞癌的发生。
Int J Cancer. 2017 Oct 1;141(7):1307-1314. doi: 10.1002/ijc.30784. Epub 2017 Jun 30.
10
Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma.肝细胞癌的全球流行病学、预防与管理
Am Soc Clin Oncol Educ Book. 2018 May 23;38:262-279. doi: 10.1200/EDBK_200939.

引用本文的文献

1
Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study.代谢相关脂肪性肝病患者发生肝功能障碍的演变及其与肝细胞癌风险的关系:一项全国性队列研究。
Clin Mol Hepatol. 2024 Jul;30(3):487-499. doi: 10.3350/cmh.2024.0145. Epub 2024 May 7.